Glenmark is a research‐led, global pharmaceutical company, with presence across branded, generics, and OTC segments; our focus therapy areas are Respiratory, Dermatology and Oncology. We are focused on developing bioequivalent as well as innovative medicines that make a difference to the NHS and fulfil the unmet needs of patients

NP-UK-GLEN-0235 – May 2026